Remove 2022 Remove Heart Disease Remove Hypertension
article thumbnail

Cardiovascular outcomes in long COVID-19: a systematic review and meta-analysis

Frontiers in Cardiovascular Medicine

Systematic search conducted without language restrictions from December 1, 2019 to June 31, 2022 on PubMed, EMBASE, Web of Science, Cochrane library, ProQuest Coronavirus Research Database, COVID-19 Living Overview of the Evidence (L-OVE) subset of Episteminokos and the World Health Organization (WHO) Covid-19 databases.

article thumbnail

Forecasting the Economic Burden of Cardiovascular Disease and Stroke in the United States Through 2050: A Presidential Advisory From the American Heart Association

Circulation

Annual inflation-adjusted (2022 US dollars) health care costs of cardiovascular risk factors are projected to triple between 2020 and 2050, from $400 billion to $1344 billion.

article thumbnail

FAQs about the Cardiology Recertification Exam

BoardVitals - Cardiovascular

In early 2022, the ABIM updated its fee structure to help physicians pay less over time to maintain their certifications. The Cardiology MOC exam covers the following subjects : Arrhythmias 15% Coronary Artery Disease 21.5% Here are some common questions surrounding the Cardiology MOC Exam: When is the Cardiology MOC exam offered?

article thumbnail

American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary

DAIC

24: Joint American College of Cardiology/Journal of the American College of Cardiology Late-Breaking Clinical Trials (Session 402) Saturday, April 6 9:30 – 10:30 a.m.

article thumbnail

Exploring Obesity and the Latest Advances in Weight Loss Drugs during Healthy Weight Week

Cardiometabolic Health Congress

It increases the likelihood of developing chronic conditions such as heart disease, diabetes, and high blood pressure. Food and Drug Administration (FDA) in 2021 as a once-weekly injection for chronic weight management in adults with obesity and at least one weight-related condition such as type 2 diabetes or hypertension.

Obesity 97
article thumbnail

ECG Blog #425 — Are there P Waves?

Ken Grauer, MD

PEARL # 1: Given a potentially longterm course for the patient with an ASD — it's important to appreciate that a lack of symptoms does not necessarily exclude the possibility of hemodynamically significant heart disease.

Blog 115
article thumbnail

Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pacemaker Patients

DAIC

The BACKBEAT pivotal study will evaluate the efficacy and safety of atrioventricular interval modulation (“AVIM”) therapy (also known as BackBeat CNT), for the treatment of pacemaker-indicated patients with uncontrolled hypertension despite the use of antihypertensive medications. Orchestra BioMed and Medtronic, Inc. Kowal, M.D., and Europe.

Pacemaker 105